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Macrophage Induction of T-Suppressor
Cells in Pesticide-Exposed and
Protozoan-Infected Mice
by Leland D. Loose*
The use of infectious pathogens has allowed the detection of the development of synergism
between pathogens and ubiquitous environmental chemical contaminants. This synergism has
been demonstrated to result in a state of immunosuppression which either did not occur in the
independent and singular presence ofthe chemical or pathogen and/or was greater than additive
when both were combined. The immunosuppression wasdistinct with regard tothe organochloride
used and, therefore, is ngt a ubiquitous characteristic ofall organohalides. The production of a
macrophage soluble factor which appeared to induce T-suppressor cells was demonstrated in
hepatic Kupffer cells from mice administered 5 ppm of dieldrin for 10 weeks and then infected
with Leishmania tropica promastigotes. The factor was not generated in mice administered
dieldrin and infected with malaria nor in mice administered only dieldrin nor in mice only infected
with Leishmania. Additional studies revealed a profound impairment in macrophage antigen
processing with macrophages obtained from mice administered dieldrin. The use of pathogen
models may allow the immunosuppressive potential ofenvironmental chemical contaminants to
be expressed in a more sensitive manner.
Introduction
Previous studies have demonstrated that envi-
ronmental chemical contaminants impair host de-
fense responses to a malaria challenge and to
gram-negative endotoxin (1). In conjunction with
these alterations, a significant reduction in anti-
body formation to sheep erythrocytes, (SRBC), a
T-dependent and macrophage-processed antigen,
was observed (2). These functional alterations were
demonstrated in the absence of any lymphoid histo-
pathologic changes. Further studies to examine
cell-mediated immunity (CMI) in the xenobiotic
treated mice revealed an essentially normal CMI
responsiveness as measured by the graft-versus-
host assay, mixed lymphocyte culture reaction,
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polyclonal mitogen activity and lymphocytotoxicity
response (3). Sinceitwas felt that the CMI parame-
ters which were measured and which were unal-
tered were, in general, macrophage-independent
whereas the response to malaria, endotoxin and
SRBC were macrophage-dependent, the cellular
lesion responsible for the impaired malaria, endo-
toxin and SRBC responses could reside at the level
ofthe macrophage.
Measurements of macrophage affector activity,
i.e., cellular respiration, phagocytic activity, phago-
cytic capacity and chemotaxis revealed no alter-
ationintheseparameters (4). However, macrophage
effector activity, i.e., antigen processingand tumor
cell killing were significantly impaired (5). There-
fore, it was speculated that if the cellular lesion
responsible for the xenobiotic-induced immunosup-
pression was at the level of the macrophage, that
the lesion could be due to: a functional impairment
in the macrophage, induction of a population of
suppressor macrophages, production of suppressor
89factors from the macrophage or a combination of
one of the above.
Therefore, further studies were conducted to
determine the contribution of the macrophage to
xenobiotics-induced immunosuppression. Thepossible
development of a synergistic reaction between the
influence ofthe xenobiotics onthe immune response
and a concomitant protozoan infection was ascer-
tained concurrently.
Materials and Methods
Animals
Male BALB/c mice (18-20 g) were used through-
out all studies.
Chemicals
Dieldrin (Shell) and hexachlorobenzene (HCB,
Eastman) were administered in the diet at 1 and 5
ppm and 5 and 100 ppm, respectively. Control mice
received untreated powdered Wayne Lab Blox.
Food and water were provided ad libitum, and a
12:12 day:night photoperiod was maintained. Di-
etary administration ofthe test chemicals was for3,
5 or 10 week periods.
Parasites
Plasmodium berghei (NYU-2) was passaged week-
lybyintraperitoneal (IP) injection of1 x 106infect-
ed erythrocytes. The survival time ofinfected mice
injected with this strain of murine malaria at the
stated inoculum was approximately 10-12 days.
Leishmania tropica was initially derived from a
biphasic blood agar medium and then adapted to a
defined culture medium consisting of MEM 199
with 10% heat inactivated fetal calf serum. Subcul-
tures were made weekly. The parasite stage used
was a promastigote in a mid- to late-log phase.
Survival time of BALB/c mice injected intrader-
mally (ID) with 1 x 106 promastigotes was approx-
imately 15-20 weeks.
Antibody Formation
Antibody production was assessed using the di-
rectJerne and Nordin (6) plaque assay as previous-
ly described (2). Plaque formation to polyvinylpyr-
rolidine (PVP, Sigma), a T-independent antigen,
utilized passively sensitized SRBC coated with PVP
by the method of Boyden (7). Preliminary studies
revealed that the kinetics of splenic plaque forma-
tion in experimental and control mice were compa-
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rable and, therefore, only day 4 was used to
subsequently enumerate plaques.
Mononuclear Spleen Cell Populations
Splenic T- and B-lymphocytes were enumerated
as previously described (8). T-cells were detected
by the presence oftheta antigen (Thy-1) and subse-
quent cytotoxicity induced by anti-theta serum.
B-cells were detected by the presence of surface
immunoglobulin (Ig) using fluorescein-tagged, goat
anti-mouse Ig. Splenic macrophages were stained
by the method of Yam, Li and Crosby (9), which
detects the presence of surface neutral esterase, a
cytochemical marker for macrophages.
Lymphocyte Blastogenesis
Spleens were removed aseptically from mice,
controls and experimentals, at the stated intervals
(see Tables 5-8), and teased apart in cold RPMI
1640 and strained through a lOxx silk cloth. This
single cell suspension was then passaged through
nylon wool (Leuko-Pak leukocyte filter, Fenwal
Labs, Deerfield, Ill.) which was soaked in saline for
2 hr at 37°C then rinsed three times in doubly
distilled water for 3 days, autoclaved and then
dried. A 60-ml disposable syringe barrel was then
packed with 6 gofnylonwool and then washed with
20 ml ofRPMI 1640 containing 5% fetal calfserum.
The columns were then drained and placed in a
37°C incubator for 1 hr prior to being loaded with
108 spleen cells in 20 ml ofRPMI 1640. The column,
with the cells, was incubated at 37°C for 45 min
prior to eluting the cells at a 1 ml/min rate. The
T-cell enriched suspension was then concentrated
by centrifugation at 250 g for 15 min. Cell viability,
as determined by trypan blue dye exclusion, was
> 85%, and > 95% ofthe cells were theta positive.
The enriched T-cell population was then dispensed
in 200 ,ul volumes containing 4 x 105 cells into
Linbro flat-bottomed microtest plates (Flow Lab).
The RPMI 1640 medium was supplemented with
2mM L-glutamine, 10% fetal calf serum, 50-100
units ofpenicillin and 50-100 pugofstreptomycin/ml.
In addition, phytohemagglutinin (PHA-M, B grade,
Difco) was added at a concentration of 0.1 ,ug/well.
The plates were incubated at 37°C in humidified 5%
CO2 for 48 hr, after which 0.1 ,uCi of 3H (specific
activity 5 Ci/mmole) was added and the plates incu-
bated for an additional 16 hr prior to harvest. Cell
harvesting was conducted as previously described
(3), and data are presented as cpm x i03. Anti-
theta serum treatment of the nylon wool enriched
T-cell preparation utilized a 1:80 dilution ofanti-Thy-1
antiserum (Cedarlane Labs) and a 1:10 dilution of
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30 min at 37°C. Mitomycin C treatment consisted of
incubating the nylon wool passaged cells (107/ml)
with 20 ,ug of mitomycin C (Sigma) for 25 min at
37TC. The cells were washed three times in RPMI
1640 prior to use in blastogenesis studies (3).
Macrophage Assay
Alveolar, splenic and peritoneal macrophages were
isolated as previously described (4). Briefly, alveo-
lar macrophages were isolated by lavage ofthe lung
with saline, peritoneal macrophages were isolated
by saline lavage of the peritoneal cavity, and sple-
nic macrophages were isolated by surface adsorp-
tion. Hepatic Kupffer cells were isolated by partial
enzymatic digestion of the liver as described by
Stege et al. (10). The macrophage preparations
were incubated overnight in RPMI 1640 plus 10%
FCS in a 5% C02:humidified atmosphere at a cell
concentration of 1 x 107 cells/culture plate. The
following day the cell supernatant was decanted off
and centrifuged at 250 g for 20 min to remove cell
debris. A 50 ,ul aliquot ofthis supernatant was then
added to the T-cell blastogenesis cultures, replac-
ing 50 RIl ofthe RPMI 1640 medium. PHA-induced
blastogenesis studies were then conducted as de-
scribed above.
Macrophage antigen processing of SRBC, a T-
dependent antigen which requires macrophage co-
operation for immunogenicity, was conducted as
previously described (5).
Statistics
Alldata arereported asthe meanwithsignificance
denoted by an asterisk where p < 0.05. Significance
was determined by using the Student's t test.
Significance for mortality data was calculated using
the time-effect evaluation of Litchfield (11).
Results
As can be seen in Table 1, the addition ofeither 1
or 5 ppm ofdieldrin to the diet ofmice exacerbated
the lethality induced by a challenge infection with
either the malaria parasite Plasmodium berghei
(NYU-2) or Leishmania tropica. The lethality
synergized by dieldrin and the parasites appeared
to be both time and dose related. However, mice
administered 5 or 100 ppm of HCB and then chal-
lenged with malaria or Leishmania expressed a
synergy only with Leishmania and not malaria. The
mortality induced by Leishmania was more marked
in dieldrin-exposed mice than in HCB-exposed mice.
When the dieldrin and HCB-treated mice which
were infected with malaria or Leishmania and then
evaluated for their ability to produce antibody to
SRBC, asuppressive synergism was noted primari-
ly in HCB-treated mice (Table 2). In these mice,
the splenic plaque forming response was more sup-
pressed in the combination ofHCB + infected mice
than in those only HCB-treated or only infected. In
dieldrin-treated mice, a synergism was observed
only in mice which received 5 ppm of dieldrin plus
infection with Leishmania.
Although a suppressed SRBC response was noted
in HCB-treated mice infected with either malaria
or Leishmania, a decreased antibody formation to
PVP, a T-independent antigen, was observed only
in Leishmania-infected mice exposed to dieldrin or
HCB. Malaria did not act synergistically with diel-
drin or HCB to elicit an impaired response to PVP
(Table 3). The decreased antibody formation to
PVP in dieldrin- and HCB-treated mice infected
with Leishmania was time- and dose-related in
dieldrin-treated mice but was only time-related in
HCB-treated mice.
An examination ofthe number ofsplenic T-cells,
B-cells and macrophages revealed no consistent
significant alterations in the cell types in either
Table 1. Mortality in Plasmodium berghei and Leishmania tropica infected mice administered dieldrin or HCB.a
Mean survival time, daysb
Dieldrin, 1 ppm Dieldrin, 5 ppm HCB, 5 ppm HCB, 100 ppm
Weeks Malaria Leishmania Malaria Leishmania Malaria Leishmania Malaria Leishmania
3 10.4 123.5 10.8 80.8* 12.0 97.6* 11.1 73.7*
6 10.6 81.2* 7.2* 57.7* 11.9 83.1* 9.8 60.0*
10 7.1* 53.9* 4.7* 23.0* 10.8 75.6* 7.0* 41.1*
Control: 12.3 119.0
aMale BALB/c mice (18-20 g) were administered dieldrin or HCB at 1 and 5 or 5 and 100 ppm, respectively, for3, 6 or 10 weeks and
then challenged with either 1 x 105 Plasmodium berghei (NYU-2) infected erythrocytes (IP) or 1 x 106 Leishmania tropica
promastigotes injected ID.
bMean survival time (days) is denoted for experimental and control mice and significance is indicated by an asterisk where p < 0.05;
n = 12 per group. Following injection of the parasite(s) all dietary administration of HCB or dieldrin ceased.
February 1982 91Table 2. Direct splenic plaque formation to SRBC in mice infected with malaria or Leishmania with administration ofdieldrin
or HCB.a
Chemical treatment Splenic PFC/106 cells
Time, weeks Agent Concn, ppm No infecting organism Malaria Leishmania
- None 255b 107C 186C
3 Dieldrin 1 240d 128 190
5 137d 91 76
6 Dieldrin 1 200d 117 133
5 91d 72 43
10 Dieldrin 1 107d 99 101
5 50d 38 21
3 HCB 5 280d 148 107
100 172d 72 58
6 HCB 5 248d 109 82
100 103d 40 37
10 HCB 5 176d 77 49
100 69d 19 15
aSplenic PFC/106 cells determined on day 4 following 10 infection of0.1 ml of 10% SRBC. Malaria-infected mice (1 x 105 parasites,
IP) were immunized on day 3 post infection, and Leishmania infected mice (1 x 106 promastigotes, ID) were immunized 20 days post
infection.
bControl consisting of untreated but immunized mice.
cControl consisting of PFC responses in infected mice receiving no chemical treatment.
dControl consisting of chemically treated, on infected mice.
chemical treated, infected or chemical-treated plus
infected mice as compared to control values (Table
4). The only statistically significant alteration oc-
curred in the 5 ppm dieldrin-treated plus Leish-
mania-infected mice at the 10 week exposure period
in which a significant decrease in macrophages,
T-cells and B-cells was observed as compared to
normal controls, infected animals, or 5 ppm dieldrin
at the 10 week exposure period.
In contrast to the apparent absence ofany consis-
tent alteration in T-cell numbers in chemical-treated
plus infected mice, a significant depression in HCB
and dieldrin-treated plus Leishmania-infected mice
to the T-cell mitogen, PHA, was demronstrated
(Table 5). Isolated splenic T-cells from Leishmania-
infected mice which had been administered dieldrin
or HCB had a significantly depressed response to
the polyclonal T-cell mitogen PHA. Neither diel-
drin or HCB alone or malaria or Leishmania infec-
tion alone caused any change in the splenic T-cell
enrichedpopulation response toPHA. Furthermore,
malaria infection in dieldrin or HCB-treated mice
Table 3. Direct splenic plaque formation to PVP in mice infected with malaria or Leishmania with administered dieldrin or
HCB.a
Chemical treatment Splenic PFC/106 cells
Time, weeks Agent Concn, ppm No infecting organism Malaria Leishmania
- None 287b 180C 267C
3 Dieldrin 1 290 205 199
5 250 222 133
6 Dieldrin 1 277 227 150
5 233 197 99
10 Dieldrin 1 249 173 93
5 200 172 42
3 HCB 5 269 293 174
100 241 214 142
6 HCB 5 248 254 129
100 223 188 101
10 HCB 5 257 231 87
100 189 153 76
aPVP (Sigma) was administered IP at a dose of 2.5 ,ug/mouse to mice infected with P. berghei (1 x 105 parasites, IP) on day 4
post-immunization and to mice infected with L. tropica (1 x 106 promastigotes, ID) on day 20 post infection.
bUntreated, uninfected mice.
cDirect plaques were enumerated on day 4 post immunization, n = 12.
Environmental Health Perspectives 92Table 4. Mononuclear (T, B, M4) cells in mice infected with malaria or Leishmania and receiving dieldrin or HCB.a
Chemical treatment Mononuclear cells
Time, weeks Agent Concn, ppm Infecting organism T, % B, % M+, %
- None - None 30 51 12
- None - Malaria 34 60 15
- None - Leishmania 31 58 13
3 Dieldrin 1 None 33 54 15
Malaria 33 50 12
Leishmania 30 50 15
3 Dieldrin 5 None 20 49 18
Malaria 24 56 10
Leishmania 32 47 10
6 Dieldrin 1 None 29 48 12
Malaria 30 52 15
Leishmania 24 41 12
6 Dieldrin 5 None 30 42 10
Malaria 27 57 12
Leishmania 24 40 8
10 Dieldrin 1 None 37 50 12
Malaria 27 46 9
Leishmania 23 37 10
10 Dieldrin 5 None 27 40 14
Malaria 20 60 12
Leishmania 19 41 5
3 HCB 5 None 30 49 12
Malaria 32 54 12
Leishmania 33 50 10
3 HCB 100 None 27 57 14
Malaria 31 50 15
Leishmania 30 46 9
6 HCB 5 None 28 51 15
Malaria 32 51 14
Leishmania 37 49 11
6 HCB 100 None 25 54 11
Malaria 31 46 12
Leishmania 29 40 11
10 HCB 5 None 34 47 10
Malaria 30 47 16
Leishmania 28 47 9
10 HCB 100 None 27 42 13
Malaria 26 40 11
Leishmania 27 48 9
aMononuclear splenic cells (T-cells, B-cells, and macrophages) as mean percentages; n = 12. Cellular populations were enumerated
on day 4 in malaria-infected mice (P. berghei, 1 x 105, IP) and day 20 in Leishmania-infected (1 x 106 promastigotes, ID) mice.
did not alter PHA responsiveness. The dieldrin +
Leishmania-induced impairment in PHA activity
was time- and dose-related, whereas the change
seen in HCB + Leishmania-infected animals was
only time-related, i.e., exacerbation with extended
dietary administration of HCB.
To further evaluate the impaired PHA respon-
siveness in dieldrin-treated mice infected with
Leishmania, the splenic T-cell enriched population
was subjected to mitomycin C and anti-theta (anti-T
hy-1) serum. Mitomycin C and anti-theta serum
abolished the mitogenic response to PHA, as mea-
sured by3H-thymidine incorporation. When splenic
T-cells taken from dieldrin + Leishmania infected
mice were added at one-halfthe normal cell concen-
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tration (4 x 105) tonormal (control) splenicT-cells a
significant inhibition was demonstrated (Tables 6
and7. Thisinhibitioncouldbeblockedbypretreating
the dieldrin + Leishmania-infected mouse derived
T-cells with mitomycin C which suggested an active
cell-mediated suppressor. Similarly, when the sple-
nic T-cells from the dieldrin + Leishmania-infected
mice were pre-treated with anti-Thy-1 antiserum
their inhibitory or suppressive effect was also abol-
ished. These data suggested the presence ofa Thy-1
positive suppressor cell in the spleen of the
dieldrin-treated/Leishmania-infected mice.
Since the Leishmania promastigote has been de-
scribed as a parasite infecting and proliferating in
macrophages it was subsequently decided to de-
93Table 5. PHA response of splenic T-cell nylon wool-enriched populations from mice infected with malaria or Leishmania and
receiving dieldrin or HCB.'
Chemical treatment PHA response, cpm x 103
Time, weeks Agent Concn, ppm No infecting organism Malaria Leishmania
_ _ _ 39 41 44
3 Dieldrin 1 48 43 40
5 53 39 22
6 Dieldrin 1 49 37 36
5 45 41 16
10 Dieldrin 1 41 40 29
5 44 36 11
3 HCB 5 54 36 33
100 50 37 30
6 HCB 5 42 39 29
100 41 41 22
10 HCB 5 37 35 22
100 39 33 19
aSplenic cells were isolated from malaria- and Leishmania-infected mice on days 4 and 20, respectively, post infection and eluted
from awashed nylon wool (Fenwal) column (60 ml syringe barrel) with RPMI 1646 with 5% ICS at a rate of1 ml/min. PHA (Difco) was
added at a concentration of 0.1 ,ug/well containing 200 ,ul of a 2 x 106 cell/ml suspension. All plates (Flow, Linbro microtest) were
inoculated with PHA for 48 hr with 0.1 ,uCi of 3H (5 Ci/mmole) added 16 hr before harvest.
Table 6. PHA response of mitomycin C-treated splenic T-cell
enriched population from Leishmania-infected mice adminis-
tered dieldrin.a
PHA response,
Cell origin cpm x 103
Normal 43
Normal + mitomycin C (20 ,ug/ml) 2
Leishmania (d. 20) 44
Leishmania + mitomycin C 6
Dieldrin (5 ppm, 10 wk) 40
Dieldrin + mitomycin C 3
Dieldrin/Leishmania 10
Dieldrin/Leishmania + Normal 15
Dieldrin/Leishmania (mitomycin C) + Normal 26
Half number of normal 24
Normal + normal mitomycin C-treated cells 22
aCell preparations were used as previously described in Table
5. The enriched T-cell population at a concentration of 1 x 107
cells/ml was incubated with 20 ,ug/ml ofmitomycin C (Sigma) for
25 min at 37°C. The cells were washed three times with fresh
medium and numbers adjusted for subsequent use. Each study
was conducted in triplicate.
termine if macrophage dysfunction contributed to
the induction ofthe Thy-1 positive suppressor cells.
Hepatic Kupffer cells, alveolar, splenic and perito-
neal macrophages isolated from dieldrin treated (5
ppm, 10 wk) Leishmania-infected (day 20) mice
were cultured for 24 hr, after which their superna-
tant, following centrifugation at 250g at 4°C for 15
min, was added to cell cultures simultaneously with
PHA. Supernatant from hepatic Kupffer cells, and
to a lesser extent from splenic macrophages, but
not aveolar orperitoneal macrophages, when added
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Table 7. PHA response of anti-theta treated splenic T-cell
enriched population from Leishmania-infected mice adminis-
tered dieldrin.a
PHA response,
Cell origin cpm x 103
Normal 49
Normal + anti-theta 4
Leishmania (d. 20) 43
Leishmania + anti-theta 5
Dieldrin (5 ppm, 10 wk) 48
Dieldrin + anti-theta 2
Dieldrin/Leishmania 12
Dieldrin/Leishmania + Normal 14
Dieldrin/Leishmania (anti-theta) + Normal 30
Half number of normal 21
Normal + normal anti-theta treated cells 20
aAll cells were prepared as described. Nylon-wool passaged
spleen cells were incubated with a 1:80 dilution of anti-thy-l
antiserum (Cederlane Labs) and a 1:10 dilution of rabbit
complement.
to either control T-cells or T-cells from Leishmania-
infected mice did not alter their response to PHA,
however, when added to T-cells from dieldrin- or
HCB-treated mice or from dieldrin/Leishmania-
infected mice, the supernatant suppressed the T-cell
response to PHA (Table 8). Supernatant from mac-
rophage populations from dieldrin-treated mice or
Leishmania-infected mice did not alterthe response
to PHA. The suppressive activity was removed
from the supernatant when dialyzed against
phosphate-buffered saline overnight at 4°C.
The production by hepatic Kupffer cells, and to a
lesser extent splenic macrophages, ofa suppressive
Environmental Health PerspectivesTable 8. Macrophage induced alteration of PHA response of
splenic T-cell enriched population from Leishmania-infected
mice administered dieldrin.a
PHA response,
Cell origin cpm x 103
Normal 48
Normal + M4 46
Leishmania (d. 20) 43
Leishmania + Mo 49
Dieldrin (5 ppm, 10 wk) 43
Dieldrin + M4 18
Dieldrin/Leishmania 11
Dieldrin/Leishmania + M4 6
HCB (100 ppm, 10 wk) + M4 15
Halfnumber of normal 25
aCells were prepared as described. Hepatic Kupffer, alveolar,
splenic and peritoneal macrophage were isolated from dieldrin-
treated Leishmania infected (d. 20) mice and cultured in RPMI
1640 + 10% FCS for 24 hr. Their supernatant was added to
lymphocyte cultures simultaneously with the PHA; 50 R1I ofthe
supernatant was contained in each well.
factor which impaired T-cell responses to PHA was
correlated with the ability of hepatic macrophage
from dieldrin/Leishmania treated mice to process
an antigen and to transfer an adequate immunogen
to a recipient control animal. Similar alterations
were observed with splenic macrophages but to a
lesser degree (Table 9). The impaired antigen pro-
cessing capability was correlated with dietary ex-
posure time.
Discussion
Extensive interest in immunotoxicology has been
generated within the past 5-6 years by the demon-
stration that various environmental chemical con-
taminants may, in laboratory situations, be im-
munosuppressive. However, apartfromcontactder-
matitis, clinical evidence indicating environmental
chemical-induced immune alteration has not been
available; although several examples ofautoimmune
diseases generated by chemical exposure havebeen
reported (12, 13).
Experimental immunotoxicologic data have pri-
marily focused on evaluating the immunosuppres-
sive effect of various environmental chemical
Table 9. Macrophage presentation of antigen in mice infected with malaria and Leishmania and receiving dieldrin or HBC.a
PFC/106 spleen cells
No infecting
Time, weeks Chemical Macrophage donor type organism Malaria Leishmania
- Peritoneal 110 90 79
Splenic 150 105 83
Alveolar 91 79 64
Hepatic 77 56 43
3 Dieldrin Peritoneal 91 77 69
(5 ppm) Splenic 109 120 71
Alveolar 82 84 74
Hepatic 86 61 30
HCB Peritoneal 99 93 86
(100 ppm) Splenic 130 101 80
Alveolar 115 89 69
Hepatic 79 77 32
6 Dieldrin Peritoneal 76 61 43
(5 ppm) Splenic 85 103 32
Alveolar 70 79 58
Hepatic 71 44 77
HCB Peritoneal 68 89 61
(100 ppm) Splenic 117 90 63
Alveolar 103 76 53
Hepatic 58 84 26
10 Dieldrin Peritoneal 54 48 30
(5 ppm) Splenic 71 74 20
Alveolar 54 87 37
Hepatic 68 37 16
HCB Peritoneal 61 77 32
(100 ppm) Splenic 102 79 56
Alveolar 89 83 49
Hepatic 41 50 20
aMacrophages were isolated from dieldrin (5 ppm)- and HCB (100 ppm)-treated mice infected with malaria orLeishmania on days 4
and20, respectively. SRBC wereopsonized in50% FCS for 30 min and labeled withNa5lCrO4. A standardized inoculum of51Cr-SRBC
was injected IV into control BALB/c mice and PFC/106 cells were determined on day 4; n = 10.
95 February 1982contaminants, food additives, drugs and physical
agents while, in general, disregarding the possible
immunostimulation that may occur. In this regard,
time and dose may be the critical determinants
deciding whether a chemical contaminant is consid-
ered to be an immunostimulant or immunosuppres-
sant. Furthermore, the catabolic capability of the
lymphoid-macrophage elements at both a basal level
and at an immune and/or stimulated level have been
neglected.
Since the immune response of an organism is a
complex multicellular and humoral event an evalua-
tion of a chemical as an immunosuppressant should
initially encompass an immune parameter which is
a maximal determination ofthe host immune capac-
ity. Such a measurement is best reflected in the
assessment of the host defense using a challenge
with a pathogen. The pathogen used may be a
bacterium, virus or complex parasite. Indeed, a
systematic evaluation of cell-mediated immunity
and humoral immunity may be conducted using a
series of various pathogens.
In addition to microbial pathogens, suitable para-
sitic models are also available. Commonly used
parasites for immunological studies are: Schistosoma
mansoni, Trichinellaspiralis,Plasmodiumberghei,
Toxoplasmagondii, Trypanosoma cruzi, andLeish-
mania tropica. The present study utilized two of
these parasites, Plasmodium berghei (NYU-2) and
Leishmania tropica, to evaluate the influence of
two common environmental chemical contaminants
dieldrin and hexachlorobenzene (HCB) on host de-
fense capacity and immune competence. Plasmodi-
um berghei (NYU-2) is a lethal murine malaria
which evokes a T-cell, B-cell and macrophage re-
sponse. Although it is lethal, survival time is a
reflection of immune competence. The L. tropica
promastigote is a macrophage parasite which may
or may not survive and proliferate in tissue macro-
phages depending on their functional status (14).
In the present study host defense mechanisms
were more significantly impaired in dieldrin-treated
mice than in mice receiving HCB. Indeed, the
Leishmania model did appearto be amore sensitive
indicator ofimmunotoxicity since mice bearing this
parasite had a marked lethality whether treated
with dieldrin or HCB (Table 1). However, immuno-
suppressive synergism to a T-dependent antigen,
SRBC, in the parasite and chemical-treated mice
was more evident in mice exposed to HCB than to
dieldrin (Table 2). It appeared that the chemical
and not the parasite was the determining factor in
the antibody response to SRBC. However, when a
T-independent antigen was used, i.e., PVP, the
onlystatistically significantimmunosuppressive syn-
ergism occurred in dieldrin and HCB-treated mice
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bearing the Leishmania parasite. Since the anti-
body response to PVP has been reported to be
macrophage-independent (15) it would suggest that
B-cells/plasma cells arethe target celltypeinvolved.
Lack ofan altered response to T-independent anti-
gens in malaria infected mice has been reported.
Since a significant decrease in splenic T-cells, B-cells
and macrophages was only seen in the dieldrin/
Leishmania treated mice in the 5 ppm-10 week
group, a change in gross cellularity would seem not
to be a causal factor. However, a functional alter-
ation can obviously not be excluded.
In this regard, the marked synergism between
Leishmania in both dieldrin- and HCB-treated mice
in regard to their response to PHA denotes a very
selective cellularimpairment in T-cell functionality.
Since the 5 ppm-10 wk dieldrin/Leishmania-treated
group demonstrated the most consistent alteration
in immune parameters, i.e., depressed SRBC re-
sponse, depressed PVP responses, and decreased
T, B and MO numbers and depressed PHA re-
sponse, this group of animals was examined in
greater detail for cellular hypofunctionality.
Treatment of splenic T-cell enriched populations
from the dieldrin/Leishmania treated mice with mi-
tomycin C to inhibit DNA synthesis or with antise-
rum to the Thy-1 antigen blocked their ability to
inhibit the PHA response of normal T-cells. The
inhibitory or suppressing activity suggested the
presence ofThy-1 positive DNA synthesizing T-cells.
Since induction ofT-suppressor cells by macrophages
has been demonstrated (16) the contribution of
macrophages from dieldrin/Leishmania to the in-
duction ofT-suppressor cells (T.) was investigated.
Isolated hepatic, and to a lesser extent splenic,
macrophages produced adialyzable factorthat when
added with PHA to splenic T-cell cultures, sup-
pressed PHA stimulation of the T-cells. This mac-
rophage T-cell suppressor factor did not influence
normal control cells nor T-cells from Leishmania
infected mice. However, when added to T-cells
from dieldrin/Leishmania mice or dieldrin or HCB-
treatedmiceitinhibited theirproliferative response.
The inhibition seen in HCB derived T-cells sug-
gests that the factor may act on organohalide-
primed cells. Although activated macrophages have
been demonstrated to secrete inhibitory factors
(17) previous studies have shown that macrophages
from organohalide xenobiotics are not activated (4).
Indeed, as observed in Table 9, the inability ofthe
macrophages to present an adequate immunogen to
naive hosts indicates a suppressed state.
The demonstration that maximal suppressor fac-
tor was found associated with hepatic Kupffer cells
may be, in part, related tohepatotoxicity ofthe two
xenobiotics. If this is the case, it may provide a
Environmental Health Perspectivesvaluable tool in the study of the relationship be-
tween hepatotoxicity and immunosuppression.
Further studies to elucidate the factor produced
by the suppressor macrophages will evaluate inter-
feron production as well as prostaglandins which
have immunomodulatory roles (18). In addition,
macrophage secreted factors may also compete with
thymidine for its uptake into DNA by T-cells.
The incorporation of infectious disease models
into immunotoxicologic studies may be a more rele-
vant as well as more sensitive indicator of im-
munotoxicity. Although most studies have utilized
mature animals, the use of neonates and aged ani-
mals in conjunction with stress may be a more
accurate measurement of immune potential.
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